Karen J. Wilson joins Serina Therapeutics' Board of Directors, bringing extensive experience

From GlobeNewswire: 2025-01-14 17:25:00

Serina Therapeutics, Inc. has appointed Karen J. Wilson to its Board of Directors. Wilson brings over 30 years of leadership experience in the life sciences sector and currently serves on the boards of several biopharma companies. Serina’s proprietary POZ technology aims to improve drug delivery via subcutaneous injection, providing greater control and precision. The company also announced the departure of Steven Mintz from its Board of Directors. Serina is focused on developing drug product candidates to treat neurological diseases and other indications using its POZ PlatformTM. For more information, visit https://serinatherapeutics.com.



Read more at GlobeNewswire: Serina Therapeutics Welcomes Karen J. Wilson to its Board